These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26722288)

  • 61. Measurement of a Novel Biomarker, Secretory Phospholipase A2 Group IIA as a Marker of Sepsis: A Pilot Study.
    Berg E; Paukovits J; Axelband J; Trager J; Ryan D; Cichonski K; Kopnitsky M; Zweitzig D; Jeanmonod R
    J Emerg Trauma Shock; 2018; 11(2):135-139. PubMed ID: 29937645
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A Concise Update on the Relevance of Secretory Phospholipase A2 Group IIA and its Inhibitors with Cancer.
    Chen J; Ye L; Sun Y; Takada Y
    Med Chem; 2017; 13(7):606-615. PubMed ID: 28185537
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cross-talk between group IIA-phospholipase A2 and inducible NO-synthase in rat renal mesangial cells.
    Rupprecht G; Scholz K; Beck KF; Geiger H; Pfeilschifter J; Kaszkin M
    Br J Pharmacol; 1999 May; 127(1):51-6. PubMed ID: 10369455
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Halogenated phospholipids regulate secretory phospholipase A2 group IIA activity.
    Korotaeva A; Samoilova E; Pavlunina T; Panasenko OM
    Chem Phys Lipids; 2013; 167-168():51-6. PubMed ID: 23438648
    [TBL] [Abstract][Full Text] [Related]  

  • 65. AMPK Signaling Involvement for the Repression of the IL-1β-Induced Group IIA Secretory Phospholipase A2 Expression in VSMCs.
    El Hadri K; Denoyelle C; Ravaux L; Viollet B; Foretz M; Friguet B; Rouis M; Raymondjean M
    PLoS One; 2015; 10(7):e0132498. PubMed ID: 26162096
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mice lacking secretory phospholipase A2 show altered apoptosis and differentiation with Helicobacter felis infection.
    Wang TC; Goldenring JR; Dangler C; Ito S; Mueller A; Jeon WK; Koh TJ; Fox JG
    Gastroenterology; 1998 Apr; 114(4):675-89. PubMed ID: 9516388
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Inhibitory effect of baicalin, baicalein and wogonin on secretory group IIA phospholipase A2.
    Ku SK; Lee HG; Bae JS
    Arch Pharm Res; 2015 Oct; 38(10):1865-72. PubMed ID: 25564337
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Experimental Helicobacter felis infection in transgenic mice expressing human group IIA phospholipase A2.
    Huhtinen HT; Grönroos JM; Uksila J; Grass DS; Nevalainen TJ; Laine VJ
    Helicobacter; 2004 Oct; 9(5):408-16. PubMed ID: 15361079
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Suppression of murine endotoxic shock by sPLA2 inhibitor, indoxam, through group IIA sPLA2-independent mechanisms.
    Yokota Y; Hanasaki K; Ono T; Nakazato H; Kobayashi T; Arita H
    Biochim Biophys Acta; 1999 May; 1438(2):213-22. PubMed ID: 10320804
    [TBL] [Abstract][Full Text] [Related]  

  • 70. sPLA2-IIA Augments Oxidized LDL-Induced MCP-1 Expression in Vitro Through Activation of Akt.
    Guo Y; Li B; Xu X; Wu R; Li W
    Cell Physiol Biochem; 2015; 37(4):1345-54. PubMed ID: 26488172
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Context-dependent effect of sPLA
    Chovatiya GL; Sunkara RR; Roy S; Godbole SR; Waghmare SK
    EBioMedicine; 2019 Oct; 48():364-376. PubMed ID: 31521610
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Secreted group IIA phospholipase A2 protects humans against the group B streptococcus: experimental and clinical evidence.
    Movert E; Wu Y; Lambeau G; Kahn F; Touqui L; Areschoug T
    J Infect Dis; 2013 Dec; 208(12):2025-35. PubMed ID: 23901095
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Simvastatin inhibits sPLA2 IIa expression in aorta and myocardium.
    Wei-hua L; Chang-qing S; Qiang X; Rong W; Kai-min L
    Arch Med Res; 2009 Feb; 40(2):67-72. PubMed ID: 19237014
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Analysis of secretory group II phospholipase A2 expression in human aortic tissue in dependence on the degree of atherosclerosis.
    Schiering A; Menschikowski M; Mueller E; Jaross W
    Atherosclerosis; 1999 May; 144(1):73-8. PubMed ID: 10381280
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Secretory phospholipase A2 receptor-mediated activation of cytosolic phospholipase A2 in murine bone marrow-derived mast cells.
    Fonteh AN; Atsumi G; LaPorte T; Chilton FH
    J Immunol; 2000 Sep; 165(5):2773-82. PubMed ID: 10946309
    [TBL] [Abstract][Full Text] [Related]  

  • 76. An immunohistochemical study of thioredoxin domain-containing 5 expression in gastric adenocarcinoma.
    Wu Z; Zhang L; Li N; Sha L; Zhang K
    Oncol Lett; 2015 Mar; 9(3):1154-1158. PubMed ID: 25663872
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Secretory Phospholipase A2 Is Associated with the Odds of Acute Coronary Syndromes through Elevation of Serum Amyloid-A Protein.
    Santoso A; Kaniawati M; Bakri S; Yusuf I
    Int J Angiol; 2013 Mar; 22(1):49-54. PubMed ID: 24436584
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Claudin-1, but not claudin-4, exhibits differential expression patterns between well- to moderately-differentiated and poorly-differentiated gastric adenocarcinoma.
    Tokuhara Y; Morinishi T; Matsunaga T; Ohsaki H; Kushida Y; Haba R; Hirakawa E
    Oncol Lett; 2015 Jul; 10(1):93-98. PubMed ID: 26170982
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Secretory Phospholipase A2 as a Promising Biomarker for Predicting Acute Chest Syndrome in Children With Sickle Cell Disease: A Systematic Review and Meta-Analysis.
    Alsabri M; Elsnhory AB; Alattar O; Ahmed N; Ashraf S; Alassri R
    Cureus; 2024 Sep; 16(9):e69053. PubMed ID: 39398832
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Increased cyclin T1 expression as a favorable prognostic factor in treating gastric adenocarcinoma.
    Jin JS; Lin LF; Chen JC; Huang CC; Sheu JH; Chen W; Tsao TY; Hsu CW
    Oncol Lett; 2015 Dec; 10(6):3712-3718. PubMed ID: 26788195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.